ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Theratechnologies Inc

Theratechnologies Inc (THTX)

1.87
0.12
( 6.86% )
Updated: 14:11:44
Upgrade to Real time
1.87
0.126.86%
Rendering Error
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update

Theratechnologies to Announce Fourth Quarter and Full Year 2024 Finan…

MONTREAL, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

Theratechnologies Resumes Distribution of EGRIFTA SV®

Theratechnologies Resumes Distribution of EGRIFTA SV®

MONTREAL, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

Theratechnologies Provides Update on EGRIFTA SV® Supply

Theratechnologies Provides Update on EGRIFTA SV® Supply

MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment

Theratechnologies Announces Filing of FDA Prior Approval Supplement f…

MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tes…

MONTREAL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer

Theratechnologies Announces Preliminary Tolerability and Efficacy Dat…

No dose-limiting toxicities reported in two different weekly doses in...

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

Theratechnologies Announces Exclusive Licensing Agreement with Ionis …

Addition of investigational RNA-targeted medicines build upon Theratechnologi...

Theratechnologies Announces Resumed Production of EGRIFTA SV®

Theratechnologies Announces Resumed Production of EGRIFTA SV®

MONTREAL, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

News
THTX News
Newswire
PriceSizeTypeTime
1.8710014:11:44
1.8710Odd lot14:05:54
1.8751Odd lot13:58:52
1.8738Odd lot13:49:38
1.8762Odd lot13:49:38
1.8810013:49:38
1.8820013:49:38
1.885Odd lot13:49:38
1.8910013:49:38
1.891Odd lot13:45:39
1.8960013:36:28
1.8776Odd lot13:24:04
1.8950Odd lot13:22:31
1.8696Odd lot13:21:11
1.8745Odd lot13:21:11
1.8720013:21:11
1.8760Odd lot13:21:11
1.872,30013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8720013:21:11
1.8710013:21:11
1.8710,80013:21:11
1.8710013:21:11
1.8710013:21:11
1.8710013:21:11
1.8720013:21:11
1.8710013:21:11
1.8710,80013:21:11
1.8710013:18:10
1.875Odd lot13:18:10
1.8610013:18:10
1.8695Odd lot13:18:10
1.865Odd lot13:16:03
1.8641Odd lot13:14:48
1.869Odd lot13:14:48
1.861Odd lot13:14:43
1.8610013:14:15
1.8720013:14:15
1.8720013:14:15
1.8710013:14:15
1.8710013:14:15
1.8710013:14:15
Trades

Your Recent History

Delayed Upgrade Clock